S1 Clinical diabetes & therapeutics 1
: New drug therapies and innovative management strategies
Friday 17 October 08:30~10:30 | Place: Room 2
Chairs: Kap-Bum Huh, Yong-Wook Cho
Moon Kyu Lee
Sungkyunkwan University, Korea

S1-1

SGLT2 inhibitors in the treatment of type 2 diabetes mellitus
Young Min Cho
Seoul National University, Korea

S1-2

What’s new in the incretin-based therapy?
Jeong Hee Han
Lilly Korea, Korea

S1-3

Fibroblast growth factor 21 as an emerging metabolic regulator
Jeong Taek Woo
Kyung-Hee University, Korea

S1-4

The effect of early intensive diabetes treatment on long-term glycaemic control in newly diagnosed type 2 diabetes: multicentre randomised parallel trial
S5 Clinical diabetes & therapeutics 2
: Environmental hormone and central regulation in metabolic disorder
Friday 17 October 16:10~18:10 | Place: Room 2
Chairs: Hong Kyu Lee, Dong-Sun Kim
Sang Youl Rhee
Kyung Hee University, Korea

S5-1

Heavy metal exposure and metabolic diseases in Korea: evidences based on the KNHANES
Duk-Hee Lee
Kyungpook National University, Korea

S5-2

Low dose mixture of persistent organic pollutants, obesity, and type 2 diabetes: what can we do?
Hong Won Suh
Hallym University, Korea

S5-3

The pharmacological study on the blood glucose regulation and its association with different types of diseases
Tine L.M. Hectors
University of California, Irvine, USA

S5-4

Environmental pollutants and diabetes: where are we now and where are we heading?
S10 Clinical diabetes & therapeutics 3
: Diabetes and dementia
Saturday 18 October 09:00~11:00 | Place: Room 2
Chairs: Tai Hee Lee, Seong Yeon Kim
Mi Kyoung Kim
The Catholic University of Korea, Korea

S10-1

Cognitive impairment in patients with diabetes mellitus
Jae Hong Lee
University of Ulsan, Korea

S10-2

Diabetes and Alzheimer's disease
Sun Ah Park
Soonchunhyang University, Korea

S10-3

Novel mechanism of age-dependent pathologic tau accumulations in type 2 diabetes
Bong Soo Cha
Yonsei University, Korea

S10-4

Possible therapeutic option of low-dose PPAR-γ agonist through LRP1 regulation in Alzheimer’s disease
Quick Menu
Registration
Abstract
On-line submission
Venue
venue
Top